Abstract P79: Characteristics, Management and Outcomes of Patients with Acute Coronary Syndrome: A Comparison Between the Global Registry of Acute Coronary Events (GRACE) and the Gulf Registry of Acute Coronary Events (Gulf RACE)

Author(s):  
Hamza H Awad ◽  
Mohammad Zubaid ◽  
Alawi A Alsheikh-Ali ◽  
Gordon FitzgGerald ◽  
Frederick A Anderson ◽  
...  

Background: Developing countries have been under-represented in multinational cardiovascular registries despite playing an important role in global cardiovascular burden. The Arab Middle East is a unique region of the developing world where little is known about the characteristics, clinical practices, and hospital outcomes of patients hospitalized with an ACS. The objective of this study was to compare ACS patients hospitalized in the Arab Middle East to patients enrolled in a multinational ACS registry. Methods: The study sample consisted of patients (pts) recruited in 2007 with a confirmed diagnosis of ACS, including 4,445 from the Global Registry of Acute Coronary Events (GRACE) and 6,706 from the Gulf Registry of Acute Coronary Events (Gulf RACE). Results: The average age in Gulf RACE was nearly a decade younger than GRACE (56 vs 66 years). Patients in Gulf RACE were significantly more likely to be male (5,071(76%) vs 3,072(69%)), smoke (2,452(37%) vs 1,217(28%)), be diabetic (2,745(41%) vs 1,181(27%)) and have a STEMI (2,619(39%) vs 1,504(34%)), while less likely to be hypertensive (3,364(55%) vs 2,929(66%)) compared to pts in GRACE. Patients in Gulf RACE had a significantly higher odds of receiving aspirin (6,563(98%) vs 4,181(94%)) and statins (6,079(91%) vs 3,574(81%)) and significantly lower likelihood of being treated with ACE inhibitors or ARBs (4,618(69%) vs 3,574 (81%)), β-blockers (4,361(65%) vs (3,858 (87%)) and clopidogrel (3,605(54%) vs 3,274(73%)) during hospitalization. The reperfusion strategy of choice among eligible STEMI patients was thrombolysis in Gulf RACE (1,415(84%) vs 297(24%)), while in GRACE it was PCI (805(66%) vs 139(8%)). While overall unadjusted in-hospital mortality rates were not significantly different between Gulf RACE and GRACE (247(3.7%) vs 167(3.8%)), age stratified rates were higher for Gulf RACE across all strata. After adjustment for additional potential confounders, there were no significant differences in hospital mortality of pts enrolled in the two registries. All P<0.01 Conclusions: Despite differences in demographics, clinical characteristics, and treatment strategies, short-term mortality rates are comparable between ACS pts enrolled in registries from different geographic settings.

Angiology ◽  
2011 ◽  
Vol 62 (5) ◽  
pp. 390-396 ◽  
Author(s):  
Afzalhussein Yusufali ◽  
Mohammad Zubaid ◽  
Ibrahim Al-Zakwani ◽  
Alawi A. Alsheikh-Ali ◽  
Mouaz H. Al-Mallah ◽  
...  

Heart ◽  
2012 ◽  
Vol 98 (23) ◽  
pp. 1728-1731 ◽  
Author(s):  
Prashanthi V Sangu ◽  
Isuru Ranasinghe ◽  
Bernadette Aliprandi Costa ◽  
Gerard Devlin ◽  
John Elliot ◽  
...  

2009 ◽  
Vol 157 (6) ◽  
pp. 1097-1105 ◽  
Author(s):  
Karen S. Pieper ◽  
Joel M. Gore ◽  
Gordon FitzGerald ◽  
Christopher B. Granger ◽  
Robert J. Goldberg ◽  
...  

2013 ◽  
Vol 59 (10) ◽  
pp. 1497-1505 ◽  
Author(s):  
Christian Widera ◽  
Michael J Pencina ◽  
Maria Bobadilla ◽  
Ines Reimann ◽  
Anja Guba-Quint ◽  
...  

BACKGROUND Guidelines recommend the use of validated risk scores and a high-sensitivity cardiac troponin assay for risk assessment in non-ST-elevation acute coronary syndrome (NSTE-ACS). The incremental prognostic value of biomarkers in this context is unknown. METHODS We calculated the Global Registry of Acute Coronary Events (GRACE) score and measured the circulating concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and 8 selected cardiac biomarkers on admission in 1146 patients with NSTE-ACS. We used an hs-cTnT threshold at the 99th percentile of a reference population to define increased cardiac marker in the score. The magnitude of the increase in model performance when individual biomarkers were added to GRACE was assessed by the change (Δ) in the area under the receiver-operating characteristic curve (AUC), integrated discrimination improvement (IDI), and category-free net reclassification improvement [NRI(&gt;0)]. RESULTS Seventy-eight patients reached the combined end point of 6-month all-cause mortality or nonfatal myocardial infarction. The GRACE score alone had an AUC of 0.749. All biomarkers were associated with the risk of the combined end point and offered statistically significant improvement in model performance when added to GRACE (likelihood ratio test P ≤ 0.015). Growth differentiation factor 15 [ΔAUC 0.039, IDI 0.049, NRI(&gt;0) 0.554] and N-terminal pro–B-type natriuretic peptide [ΔAUC 0.024, IDI 0.027, NRI(&gt;0) 0.438] emerged as the 2 most promising biomarkers. Improvements in model performance upon addition of a second biomarker were small in magnitude. CONCLUSIONS Biomarkers can add prognostic information to the GRACE score even in the current era of high-sensitivity cardiac troponin assays. The incremental information offered by individual biomarkers varies considerably, however.


2005 ◽  
Vol 149 (1) ◽  
pp. 67-73 ◽  
Author(s):  
Alvaro Avezum ◽  
Marcia Makdisse ◽  
Frederick Spencer ◽  
Joel M. Gore ◽  
Keith A.A. Fox ◽  
...  

2004 ◽  
Vol 93 (3) ◽  
pp. 288-293 ◽  
Author(s):  
Robert J Goldberg ◽  
Kristen Currie ◽  
Kami White ◽  
David Brieger ◽  
Phillippe Gabriel Steg ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document